IL75021A - Acid 1-) 2,4-difluorophenyl (-6-fluoro-7-halo-1,4-dehydro-4-osco-1,8-) naphthyridene-3-carboxylate and its esters. - Google Patents

Acid 1-) 2,4-difluorophenyl (-6-fluoro-7-halo-1,4-dehydro-4-osco-1,8-) naphthyridene-3-carboxylate and its esters.

Info

Publication number
IL75021A
IL75021A IL7502185A IL7502185A IL75021A IL 75021 A IL75021 A IL 75021A IL 7502185 A IL7502185 A IL 7502185A IL 7502185 A IL7502185 A IL 7502185A IL 75021 A IL75021 A IL 75021A
Authority
IL
Israel
Prior art keywords
dihydro
fluoro
oxo
salt
difluorophenyl
Prior art date
Application number
IL7502185A
Other languages
English (en)
Hebrew (he)
Other versions
IL75021A0 (en
Inventor
Hirokazu Narita
Yoshinori Konishi
Jun Nitta
Hideyoshi Nagaki
Isao Kitayama
Yoriko Kobayashi
Mikako Shinagawa
Yasuo Watanabe
Akira Yotsuji
Shinzaburo Minami
Isamu Saikawa
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13845280&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL75021(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of IL75021A0 publication Critical patent/IL75021A0/xx
Publication of IL75021A publication Critical patent/IL75021A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IL7502185A 1984-04-26 1985-04-24 Acid 1-) 2,4-difluorophenyl (-6-fluoro-7-halo-1,4-dehydro-4-osco-1,8-) naphthyridene-3-carboxylate and its esters. IL75021A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59084963A JPS60228479A (ja) 1984-04-26 1984-04-26 １，４−ジヒドロ−４−オキソナフチリジン誘導体およびその塩

Publications (2)

Publication Number Publication Date
IL75021A0 IL75021A0 (en) 1985-08-30
IL75021A true IL75021A (en) 1994-01-25

Family

ID=13845280

Family Applications (1)

Application Number Title Priority Date Filing Date
IL7502185A IL75021A (en) 1984-04-26 1985-04-24 Acid 1-) 2,4-difluorophenyl (-6-fluoro-7-halo-1,4-dehydro-4-osco-1,8-) naphthyridene-3-carboxylate and its esters.

Country Status (30)

Country Link
JP (1) JPS60228479A (nl)
KR (1) KR870001693B1 (nl)
AR (1) AR241911A1 (nl)
AT (2) AT389698B (nl)
AU (2) AU565087B2 (nl)
BE (1) BE902279A (nl)
CH (1) CH673458A5 (nl)
CS (1) CS250684B2 (nl)
DD (1) DD238795A5 (nl)
DE (2) DE3546658C2 (nl)
DK (1) DK165877C (nl)
EG (1) EG17339A (nl)
ES (2) ES8700256A1 (nl)
FI (1) FI80453C (nl)
FR (2) FR2563521B1 (nl)
GB (2) GB2158825B (nl)
HU (2) HU197571B (nl)
ID (1) ID21142A (nl)
IL (1) IL75021A (nl)
IT (1) IT1209953B (nl)
LU (1) LU85871A1 (nl)
NL (2) NL187314C (nl)
NO (1) NO162238C (nl)
NZ (1) NZ211895A (nl)
PH (3) PH22801A (nl)
PL (1) PL147392B1 (nl)
PT (1) PT80349B (nl)
RO (2) RO91871B (nl)
SE (2) SE463102B (nl)
ZA (1) ZA853102B (nl)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6172753A (ja) * 1984-09-18 1986-04-14 Dainippon Pharmaceut Co Ltd ピリジルケトン誘導体
AT392789B (de) * 1985-01-23 1991-06-10 Toyama Chemical Co Ltd Verfahren zur herstellung von 1-substituierten aryl-1,4-dihydro-4-oxonaphthyridinderivaten
AU576657B2 (en) * 1985-01-23 1988-09-01 Toyama Chemical Co. Ltd. Naphthyridine and pyridine derivatives
DE3525108A1 (de) * 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen Antibakteriell wirksame chinoloncarbonsaeureester
DE3685157D1 (de) * 1985-06-26 1992-06-11 Daiichi Seiyaku Co Pyridoncarbonsaeurederivate.
US4962112A (en) * 1987-08-04 1990-10-09 Abbott Laboratories 7-(2-methyl-4-aminopyrrolidinyl)naphthryidine and quinoline compounds
IE62600B1 (en) * 1987-08-04 1995-02-22 Abbott Lab Naphtyridine antianaerobic compounds
US4859776A (en) * 1988-03-11 1989-08-22 Abbott Laboratories (S)-7-(3-aminopyrrolidin-1-yl)-1-(ortho, para-difluorophenyl)-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid and method for its preparation
JP2844079B2 (ja) * 1988-05-23 1999-01-06 塩野義製薬株式会社 ピリドンカルボン酸系抗菌剤
DE3934082A1 (de) * 1989-10-12 1991-04-18 Bayer Ag Chinoloncarbonsaeurederivate, verfahren zu ihrer herstellung sowie ihre verwendung als antivirale mittel
CA2100242A1 (en) * 1991-01-14 1992-07-15 Soon K. Moon Quinolone compounds and processes for preparation thereof
FR2692577B1 (fr) * 1992-05-26 1996-02-02 Bouchara Sa Nouvelles quinolones fluorees, leur procede de preparation et les compositions pharmaceutiques en renfermant.
KR940014395A (ko) * 1992-12-09 1994-07-18 강박광 신규한 퀴놀론 유도체 및 그의 제조방법
KR0148277B1 (ko) * 1993-01-18 1998-11-02 채영복 신규한 플루오르퀴놀론계 유도체 및 그의 제조방법
AU4272793A (en) * 1993-04-24 1994-11-21 Korea Research Institute Of Chemical Technology Novel quinolone carboxylic acid derivatives and process for preparing the same
KR950018003A (ko) * 1993-12-09 1995-07-22 스미스클라인 비참 피엘씨 신규한 퀴놀론 유도체 및 그의 제조 방법
US5910498A (en) * 1994-10-20 1999-06-08 Wakunaga Seiyaku Kabushiki Kaisha Pyridonecarboxylic acid derivatives or salts thereof and antibacterial agents comprising the same as active ingredient
PT897919E (pt) 1996-04-19 2004-11-30 Wakunaga Pharma Co Ltd Novos derivados do acido piridonacarboxilico ou seus sais e agentes anti-bacterianos contendo-os como ingrediente activo
KR20000052892A (ko) * 1996-10-30 2000-08-25 빌프리더 하이더 나프티리딘 화합물의 제조 방법 및 신규 중간 생성물
DE19713506A1 (de) 1997-04-01 1998-10-08 Bayer Ag Verfahren zur Herstellung von 2,6-Dichlor-5-fluornicotinonitril und die chemische Verbindung 3-Cyano-2-hydroxy-5-fluorpyrid-6-on-mononatriumsalz sowie dessen Tautomere
RU2270695C2 (ru) 1999-03-17 2006-02-27 Дайити Фармасьютикал Ко., Лтд. Фармацевтическая композиция
US6441182B1 (en) 1999-06-10 2002-08-27 Bayer Aktiengesellschaft Method for the production of 2,6-dichloro-5-fluoro-nicotinic acid and coarse and particularly pure 2,6-dichloro-5-fluoro-nicotinic acid
JP3477466B2 (ja) 1999-09-02 2003-12-10 湧永製薬株式会社 キノリンカルボン酸誘導体又はその塩
AU2001286852A1 (en) * 2000-08-29 2002-03-13 Chiron Corporation Quinoline antibacterial compounds and methods of use thereof
KR100981351B1 (ko) * 2003-10-29 2010-09-10 주식회사 엘지생명과학 7-클로로-1-사이클로프로필-6-플루오로-4-옥소-1,4-디하이드로-1,8-나프티리딘-3-카복실산의 제조방법
CN101792443A (zh) * 2010-03-09 2010-08-04 北京欧凯纳斯科技有限公司 氟代喹诺酮衍生物及其制备方法和用途
JOP20190045A1 (ar) 2016-09-14 2019-03-14 Bayer Ag مركبات أميد حمض 1- أريل-نفثيريدين-3-كربوكسيليك مستبدلة في الموضع 7 واستخدامها.
CN114369092A (zh) * 2021-12-20 2022-04-19 赤峰万泽药业股份有限公司 甲苯磺酸妥舒沙星及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2125310A1 (en) * 1971-05-21 1972-11-30 Sterling Drug Inc , New York, NY (V St A) 1-alkyl-1,4-dihydro-4-oxo-1,8-naphtyridine 3-carboxylic acids antibac
AR223983A1 (es) * 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico
DE3033157A1 (de) * 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4382937A (en) 1981-02-27 1983-05-10 Dainippon Pharmaceutical Co., Ltd. Naphthyridine derivatives and their use as anti-bacterials
IE55898B1 (en) * 1982-09-09 1991-02-14 Warner Lambert Co Antibacterial agents
NZ210847A (en) * 1984-01-26 1988-02-29 Abbott Lab Naphthyridine and pyridopyrimidine derivatives and pharmaceutical compositions
IL74064A (en) * 1984-01-26 1988-09-30 Abbott Lab 1,7-disubstituted-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid derivatives and antibacterial compositions containing them
AU576657B2 (en) * 1985-01-23 1988-09-01 Toyama Chemical Co. Ltd. Naphthyridine and pyridine derivatives
DE3525108A1 (de) * 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen Antibakteriell wirksame chinoloncarbonsaeureester

Also Published As

Publication number Publication date
CH673458A5 (nl) 1990-03-15
FR2614620A1 (fr) 1988-11-04
GB8510297D0 (en) 1985-05-30
NL187314C (nl) 1991-08-16
HUT38634A (en) 1986-06-30
DK165877B (da) 1993-02-01
HU194226B (en) 1988-01-28
FI80453C (fi) 1990-06-11
RO95509B (ro) 1988-10-01
DD238795A5 (de) 1986-09-03
NO162238C (no) 1989-12-06
DE3514076C2 (nl) 1989-03-30
IT8548002A0 (it) 1985-04-26
ES8700256A1 (es) 1986-09-16
JPS6320828B2 (nl) 1988-04-30
FR2563521B1 (fr) 1989-02-03
SE8804586L (sv) 1988-12-20
ES542584A0 (es) 1986-09-16
SE463102B (sv) 1990-10-08
SE501412C2 (sv) 1995-02-13
PH22801A (en) 1988-12-12
DK185685A (da) 1985-10-27
DK165877C (da) 1993-06-21
ATA267888A (de) 1989-09-15
AU612993B2 (en) 1991-07-25
RO91871B (ro) 1987-07-31
ID21142A (id) 1999-04-29
FI80453B (fi) 1990-02-28
AU8180487A (en) 1988-03-24
AT389698B (de) 1990-01-10
AT390258B (de) 1990-04-10
EG17339A (en) 1989-06-30
NL9100648A (nl) 1991-08-01
NO162238B (no) 1989-08-21
GB2158825A (en) 1985-11-20
PT80349B (pt) 1987-09-30
PL253108A1 (en) 1985-12-17
ES8706673A1 (es) 1987-07-01
GB2191776A (en) 1987-12-23
FR2563521A1 (fr) 1985-10-31
PT80349A (en) 1985-05-01
SE8502017D0 (sv) 1985-04-25
DK185685D0 (da) 1985-04-25
DE3514076A1 (de) 1985-10-31
RO91871A (ro) 1987-07-30
IT1209953B (it) 1989-08-30
FR2614620B1 (fr) 1990-03-09
JPS60228479A (ja) 1985-11-13
AR241911A1 (es) 1993-01-29
DE3546658C2 (nl) 1992-04-02
NL8501172A (nl) 1985-11-18
ES551538A0 (es) 1987-07-01
LU85871A1 (en) 1985-12-16
PH25228A (en) 1991-03-27
SE8804586D0 (sv) 1988-12-20
GB2191776B (en) 1990-03-28
NZ211895A (en) 1988-07-28
HU197571B (en) 1989-04-28
PL147392B1 (en) 1989-05-31
BE902279A (fr) 1985-10-25
AU565087B2 (en) 1987-09-03
AU4165085A (en) 1985-10-31
GB8716897D0 (en) 1987-08-26
NO851643L (no) 1985-10-28
KR870001693B1 (ko) 1987-09-24
GB2158825B (en) 1989-01-25
FI851637A0 (fi) 1985-04-25
IL75021A0 (en) 1985-08-30
KR850007596A (ko) 1985-12-07
ZA853102B (en) 1986-12-30
RO95509A (ro) 1988-09-30
ATA122485A (de) 1989-06-15
CS250684B2 (en) 1987-05-14
PH25046A (en) 1991-01-28
FI851637L (fi) 1985-10-27
SE8502017L (sv) 1985-10-27

Similar Documents

Publication Publication Date Title
IL75021A (en) Acid 1-) 2,4-difluorophenyl (-6-fluoro-7-halo-1,4-dehydro-4-osco-1,8-) naphthyridene-3-carboxylate and its esters.
US4649144A (en) Antibacterial 7-(3-amino-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid derivatives
US5091384A (en) Anti-bacterial quinolone- and naphthyridone-carboxylic acid compounds
GB2188317A (en) 4-oxo-quinoline compounds
NO312032B1 (no) Nye kinolon- eller naftylidonkarboksylsyre-derivater eller salter derav samt anvendelse derav
KR910002645B1 (ko) 6,7-이치환 1-시클로프로필-1,4-디히드로-4-옥소-1,8-나프티리딘-3-카르복실산의 제조방법
JP2758722B2 (ja) 新規キノロンカルボン酸誘導体
JPS6233176A (ja) １，４−ジヒドロ−４−オキソナフチリジン誘導体およびその塩
EP0812838B1 (en) Pyridonecarboxylic acid derivative substituted by bicyclic amino group, ester thereof, salt thereof, and bicyclic amine as intermediate therefor
JP2704428B2 (ja) キノロンカルボン酸誘導体またはその塩
JPH03188080A (ja) ピリドンカルボン酸誘導体
US4791118A (en) Quinolonecarboxylic acid derivatives and their preparation
JPH0811749B2 (ja) 新規なキノリン誘導体およびその塩
EP0911336B1 (en) Pyridonecarboxylic acid derivatives and intermediates for the synthesis thereof
KR970001159B1 (ko) 신규 1,8-나프티리딘 유도체 및 그의 제조방법
JPH07300472A (ja) 新規キノロンカルボン酸誘導体およびその製造方法
KR100359151B1 (ko) 2환성 아미노기로 치환된 피리돈카르복실산 유도체, 그의 에스테르 및 그의 염 및 이들의 중간체인 2환성 아민
JPH037260A (ja) 新規キノロン誘導体またはその塩及びこれを含有する抗菌剤
JP2630566B2 (ja) １，４−ジヒドロー４−オキソナフチリジン誘導体またはその塩
JPS6237006B2 (nl)
JPS62195380A (ja) 新規なナフチリジン誘導体およびその塩
JPH0366688A (ja) １，４―ジヒドロ―４―オキソナフチリジン化合物
JPH0633262B2 (ja) １，４−ジヒドロ−４−オキソナフチリジン誘導体およびその塩
CS250698B2 (cs) Způsob výroby l,4-dihydro-4-oxonaftyridinových derivátů

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
EXP Patent expired